hims bpc 157 jumps more than 7% after an FDA panel recommends adding BPC-157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer Hims & Hers stock jumps

The commenter agreed with our statement in the proposed rule, that the evidence indicates that evaluation for and treatment of oral infections lead to improved outcomes and reduced risk of mortality for individuals with ESRD receiving covered dialysis services and further noted that not only does dental and oral care have the potential to improve kidney care outcomes, but it also has the potential to ultimately generate cost savings

Dabigatran: Dabigatran is administered as an inactive prodrug and requires conversion to its pharmacologically active form

Vitamin supplementation is for wellness only, and not intended to cure or treat disease

Hi Foggyme, can I find evidence of what you sate in the above reply to another member